Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EMBC NASDAQ:INMD NASDAQ:IRMD NASDAQ:MGRM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEMBCEmbecta$14.96+3.2%$11.89$9.20▼$21.48$874.94M1.11559,178 shs618,453 shsINMDInMode$14.98+4.0%$14.51$13.14▼$19.85$946.87M2943,971 shs996,099 shsIRMDiRadimed$71.99-0.2%$64.97$44.58▼$74.00$915.36M1.0145,592 shs22,289 shsMGRMMonogram Orthopaedics$5.71-3.9%$5.09$1.92▼$6.02$232.01M0.69123,082 shs112,867 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEMBCEmbecta0.00%+3.31%+44.40%+52.81%-9.00%INMDInMode0.00%+0.27%+4.24%+5.79%-2.92%IRMDiRadimed0.00%-0.62%+4.38%+18.99%+54.72%MGRMMonogram Orthopaedics0.00%-1.55%+4.96%+124.80%+133.06%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEMBCEmbecta$14.96+3.2%$11.89$9.20▼$21.48$874.94M1.11559,178 shs618,453 shsINMDInMode$14.98+4.0%$14.51$13.14▼$19.85$946.87M2943,971 shs996,099 shsIRMDiRadimed$71.99-0.2%$64.97$44.58▼$74.00$915.36M1.0145,592 shs22,289 shsMGRMMonogram Orthopaedics$5.71-3.9%$5.09$1.92▼$6.02$232.01M0.69123,082 shs112,867 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEMBCEmbecta0.00%+3.31%+44.40%+52.81%-9.00%INMDInMode0.00%+0.27%+4.24%+5.79%-2.92%IRMDiRadimed0.00%-0.62%+4.38%+18.99%+54.72%MGRMMonogram Orthopaedics0.00%-1.55%+4.96%+124.80%+133.06%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEMBCEmbecta 2.75Moderate Buy$19.0027.01% UpsideINMDInMode 2.13Hold$18.0420.44% UpsideIRMDiRadimed 3.00Buy$72.000.01% UpsideMGRMMonogram Orthopaedics 3.50Strong Buy$5.40-5.43% DownsideCurrent Analyst Ratings BreakdownLatest MGRM, INMD, IRMD, and EMBC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/26/2025EMBCEmbectaZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Strong-Buy7/30/2025INMDInModeNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold7/30/2025INMDInModeBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOverweight$24.00 ➝ $21.007/16/2025EMBCEmbectaMizuhoSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$13.00 ➝ $12.007/11/2025INMDInModeCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$15.00(Data available from 9/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEMBCEmbecta$1.12B0.78$3.34 per share4.48($12.80) per share-1.17INMDInMode$394.82M2.40$1.82 per share8.21$10.12 per share1.48IRMDiRadimed$73.24M12.50$1.58 per share45.50$6.85 per share10.51MGRMMonogram Orthopaedics$370K627.02N/AN/A$0.42 per share13.60Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEMBCEmbecta$78.30M$1.4310.464.870.837.58%-23.40%14.46%11/25/2025 (Estimated)INMDInMode$181.27M$2.476.068.23N/A44.50%18.38%16.35%10/29/2025 (Estimated)IRMDiRadimed$19.23M$1.6244.4436.00N/A26.61%23.30%20.62%10/30/2025 (Estimated)MGRMMonogram Orthopaedics-$16.33M-$0.50N/AN/AN/AN/A-126.82%-96.87%11/13/2025 (Estimated)Latest MGRM, INMD, IRMD, and EMBC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/15/2025Q2 2025MGRMMonogram Orthopaedics-$0.11-$0.16-$0.05-$0.16N/AN/A8/8/2025Q3 2025EMBCEmbecta$0.7720$1.12+$0.3480$0.78$278.15 million$295.50 million7/30/2025Q2 2025INMDInMode$0.50$0.47-$0.03$0.42$98.45 million$95.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEMBCEmbecta$0.604.01%N/A41.96%N/AINMDInModeN/AN/AN/AN/AN/AIRMDiRadimed$0.680.94%N/A41.98%1 YearsMGRMMonogram OrthopaedicsN/AN/AN/AN/AN/ALatest MGRM, INMD, IRMD, and EMBC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date8/6/2025EMBCEmbectaquarterly$0.154.14%8/29/20258/29/20259/15/20257/31/2025IRMDiRadimedquarterly$0.171.13%8/18/20258/18/20258/28/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEMBCEmbectaN/A2.471.78INMDInModeN/A9.608.58IRMDiRadimedN/A8.787.51MGRMMonogram OrthopaedicsN/A2.162.16Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEMBCEmbecta93.83%INMDInMode68.04%IRMDiRadimed92.34%MGRMMonogram Orthopaedics0.45%Insider OwnershipCompanyInsider OwnershipEMBCEmbecta0.42%INMDInMode6.92%IRMDiRadimed36.80%MGRMMonogram Orthopaedics28.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEMBCEmbecta2,10058.49 million58.24 millionOptionableINMDInMode48063.21 million58.84 millionOptionableIRMDiRadimed11012.72 million8.04 millionOptionableMGRMMonogram Orthopaedics2840.63 million29.21 millionNot OptionableMGRM, INMD, IRMD, and EMBC HeadlinesRecent News About These CompaniesMonogram Orthopaedics Faces Merger Review DelaySeptember 5 at 8:31 AM | tipranks.comWhat is Roth Capital's Forecast for MGRM Q3 Earnings?August 24, 2025 | marketbeat.comMonogram Orthopaedics (NASDAQ:MGRM) Issues Earnings Results, Misses Estimates By $0.05 EPSAugust 19, 2025 | marketbeat.comMonogram Orthopaedics Delays 10-Q FilingAugust 15, 2025 | tipranks.comZimmer Biomet Announces Second Quarter 2025 Financial ResultsAugust 7, 2025 | prnewswire.comMonogram Orthopaedics Updates on Zimmer Biomet AcquisitionAugust 3, 2025 | theglobeandmail.comMonogram Orthopaedics Initiates Mandatory Stock ConversionAugust 3, 2025 | theglobeandmail.comMonogram announces first autonomous saw-based robotic knee replacement procedureJuly 31, 2025 | massdevice.comMonogram Technologies Announces World’s First Fully Autonomous Saw-Based Robotic Knee Replacement SurgeryJuly 31, 2025 | taiwannews.com.twTMonogram Technologies Announces World's First Fully Autonomous Saw-Based Robotic Knee Replacement SurgeryJuly 29, 2025 | globenewswire.comMonogram Orthopaedics Announces Acquisition by Zimmer BiometJuly 29, 2025 | msn.comMONOGRAM TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Monogram Technologies Inc. - MGRMJuly 16, 2025 | businesswire.comMonogram Orthopaedics Ends License Agreement with Mount SinaiJuly 14, 2025 | tipranks.comMGRM Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Monogram Technologies to Zimmer BiometJuly 14, 2025 | globenewswire.comMonogram Technologies stock soars after Zimmer Biomet acquisition dealJuly 14, 2025 | in.investing.comZimmer Biomet to buy Monogram for $177M in cashJuly 14, 2025 | msn.comZimmer Biomet to expand robotic suite with Monogram acquisitionJuly 14, 2025 | massdevice.comShareholder Alert: The Ademi Firm Investigates Whether Monogram Technologies Inc. is Obtaining a Fair Price for its Public ShareholdersJuly 14, 2025 | businesswire.comMGRM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Monogram Technologies Inc. Is Fair to ShareholdersJuly 14, 2025 | businesswire.comZimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous SolutionsJuly 14, 2025 | globenewswire.comZimmer Biomet Announces Definitive Agreement to Acquire Monogram Technologies, Expanding Robotics Suite with Autonomous SolutionsJuly 14, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMGRM, INMD, IRMD, and EMBC Company DescriptionsEmbecta NASDAQ:EMBC$14.96 +0.47 (+3.24%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$14.97 +0.01 (+0.07%) As of 09/5/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.InMode NASDAQ:INMD$14.98 +0.57 (+3.96%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$14.86 -0.12 (-0.79%) As of 09/5/2025 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.iRadimed NASDAQ:IRMD$71.99 -0.15 (-0.21%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$72.06 +0.07 (+0.09%) As of 09/5/2025 04:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.Monogram Orthopaedics NASDAQ:MGRM$5.71 -0.23 (-3.87%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$5.78 +0.08 (+1.31%) As of 09/5/2025 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was founded in 2015 and is headquartered in Austin, Texas. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/01 - 09/05 Lululemon Share Price Has Plenty of Room Left to Fall Why DocuSign Could Be a SaaS Value Play After Q2 Earnings Why Hedge Fund Elliott Bet $4B on Pepsi and Sees Over 50% Upside Union Pacific: Laying the Tracks for America's Industrial Renewal TransDigm’s Edge: From Spare Parts to Sky-High Profits Palantir Insider Selling: Risk Signal or Normal Activity? Advanced Micro Devices' 2026 Forecasts Are Way Too Low Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
